Calimmune Initiates HIV Stem Cell Study at Two California Research Sites
(Los Angeles, CA) --
The
HIV gene medicines company Calimmune announced
today
that
the
first patient
has
begun treatment in
a Phase I/II
clinical trial designed
to determine
whether a pioneering genetic medicine approach can help to protect
individuals infected with
HIV from the effects of
the
virus. The study, “Safety Study of a Dual
Anti-HIV Gene Transfer Construct to Treat
HIV-1 Infection
Source: Nelson Vergel's HIV Blog - Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs